Inhibition by naloxone of promoter activity of the neurofilament gene in SK-N-SH cells

Japanese Journal of Pharmacology

Volumn 82, Issue 1, 2000, Pages 34-39

  Niu, San Yong ^a   Kuo, Che Hui ^a   Taira, Eiichi ^a   Muraoka, Osamu ^a   Irie, Yasuyuki ^a   Gan, Ye Hua ^a   Do, Eunju ^a   Miki, Naomasa ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Morphine; Naloxone; Neurofilament; Promoter; SK N SH cell

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LEVALLORPHAN; LUCIFERASE; MORPHINE; NALOXONE; NALTREXONE; NEUROFILAMENT PROTEIN; OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG INHIBITION; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MOUSE; NONHUMAN;

EID: 0033952430     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.82.34     Document Type: Article

References (27)

1. Minami M and Satoh M: Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res 23, 121-145 (1995)
2. Reisine T and Pasternak G: Opioid analgesics and antagonists. In Goodman & Gilman's the Pharmacological Basis of Therapeutics, Ninth edition, Edited by Hardman JG and Limbird LE, pp 521-537, The McGraw-Hill Companies, Inc Press, New York (1996)
3. Fukuda K, Kato S, Shoda T, Morikawa H, Mima H and Mori K: Partial agonistic activity of naloxone on the opioid receptors expressed from complementary deoxyribonucleic acids in Chinese hamster ovary cells. Anesth Analg 87, 450-455 (1998)
4. Kameyama T, Nabeshima T, Matsuno K and Suzuki M: Different changes by acute electric footshock of opioid agonist and antagonist receptors in rat brain. Neurosci Lett 49, 307-312 (1984)
5. Pogon S, Demirgoren S, Kutay FZ, Hariri NI and Karaali H: Naloxone binding in the frontal cortex of postmortem human brain. Prog Neuropsychopharmacol Biol Psychiatry 13, 167-171 (1989)
6. Hoffman PN and Lasek RJ: The slow component of axonal transport identification of major structural polypeptides of the axon and their generality among mammalian neurons. J Cell Biol 66, 351-366 (1975)
7. Willamson TL, Marszalek JR, Vechio JD, Bruijn LI, Lee MK, Xu Z, Brown RH and Cleveland DW: Neurofilaments, radial growth of axons, and mechanisms of motor neuron disease. Cold Spring Harb Symp Quant Biol 61, 709-723 (1996)
8. Hoffman PN, Griffin JW and Price DL: Slowing of neurofilament transport and the radial growth of developing nerve fibers. J Neurosci 5, 2920-2929 (1985)
9. Lasek RJ, Phillips L, Katz MJ and Gambetti AL: Function and evolution of neurofilament proteins. Ann NY Acad Sci 455, 462-478 (1985)
10. Beitner-Johnson D, Guitart X and Nestler EJ: Neurofilament protein and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J Neurosci 12, 2165-2176 (1992)
11. Boronat MA, Olmos G and Garcia-Sevilla JA: Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands. Br J Pharmacol 125, 175-185 (1998)
12. Garcia-Sevilla JA, Ventayol P, Busquets X, Harpe LR, Walzer C and Guimon J: Marked decrease of immunolabelled 68 kDa neurofilament (NF-L) protein in brains of opiate addicts. Neuroreport 8, 1561-1565 (1997)
13. Nakahira K, Ikenaka K, Wada K, Tamura T, Furuichi T and Mikoshiba K: Structure of the 68-kDa neurofilament gene and regulation of its expression. J Biol Chem 265, 19786-19791 (1990)
14. Nojima H: Structural organization of multiple rat calmodulin genes. J Mol Biol 208, 269-282 (1989)
15. Baumhaker Y, Gafni M, Keren O and Same Y: Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells. Mol Pharmacol 44, 461-467 (1993)
16. Breivogel CS, Selley DE and Childers SR: Acute and chronic effects of opioids on delta and mu receptor activation of G proteins in NG108-15 and SK-N-SH cell membranes. J Neurochem 68, 1462-1472 (1997)
17. Borowitz JL, Gunasekar PG and Isom GE: Hydrogen cyanide generation by mu-opiate receptor activation: possible neuro-modulatory role of endogenous cyanide. Brain Res 768, 294-300 (1997)
18. Venihaki M, Gravanis A and Margioris AN: Kappa opioids exert a strong antiproliferative effect on PC12 rat pheochromocytoma cells. Peptides 17, 413-419 (1996)
19. Sawynok J, Pinsky C and LaBella FS: Minireview on the specificity of naloxone as an opiate antagonist. Life Sci 24, 1621-1632 (1979)
20. Bar PR, Renkema GH, Veraart CM, Hol EM and Gispen WH: Nimodipine protects cultured spinal cord neurons from depolarization-induced inhibition of neurite outgrowth. Cell Calcium 14, 293-299 (1993)
21. Ramaswamy S, Nazimudeen SK and Kameswaran L: Effects of naloxone on the sensitivity of the vas deferens to various agonists. J Pharm Pharmacol 31, 222-223 (1979)
22. Berridge MJ: Neuronal calcium signaling. Neuron 21, 13-26 (1998)
23. Bading H, Hardingham GE, Johnson CM and Chawla S: Gene regulation by nuclear and cytoplasmic calcium signals. Biochem Biophys Res Commun 236, 541-543 (1997)
24. 2+ channel-regulated neuronal gene expression. J Neurobiol 37, 171-189 (1998)
25. Okazaki T, Zajac JD, Igarashi T, Ogata E and Kronenberg HM: Negative regulatory elements in the human parathyroid hormone gene. J Biol Chem 266, 21903-21910 (1991)
26. Okazaki T, Ando K, Igarashi T, Ogata E and Fujita T: Conserved mechanism of negative gene regulation by extracellular calcium. J Clin Invest 89, 1268-1273 (1992)
27. Izumi T, Henner WD and Mitra S: Negative regulation of the major human AP-endonuclease, a multifunctional protein. Biochemistry 35, 14679-14683 (1996)